Christian Domingo Ribas (Christian Domingo)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Chronic Obstructive Pulmonary Disease

Atopic Dermatitis

Top Venues

International journal of molecular sciences

ERJ open research

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Domingo Ribas, Daniel R Monserrate, Ana Sogo, Rosa M Mirapeix
The Incredible Adventure of Omalizumab. International journal of molecular sciences 25 (5) (2024)
Christian Domingo Ribas, Daniel R Monserrate, Ana Sogo, Rosa M Mirapeix
The Incredible Adventure of Omalizumab. International journal of molecular sciences 25 (5) (2024)
Christian Domingo Ribas, Daniel R Monserrate, Ana Sogo, Rosa M Mirapeix
The Incredible Adventure of Omalizumab. International journal of molecular sciences 25 (5) (2024)
Christian Domingo Ribas, Rosa M Mirapeix, Francisco-Javier González-Barcala, Carles Forné, Felip García
Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study. Drugs (2023)
Christian Domingo Ribas, Rosa M Mirapeix
From the Allergic Cascade to the Epithelium-Driven Disease: The Long Road of Bronchial Asthma. International journal of molecular sciences 24 (3) (2023)
Ian Douglas Pavord, Arnaud Bourdin, Alberto Papi, Christian Domingo Ribas, Jonathan Corren, Arman Altincatal, Amr Radwan, Nami Pandit, Juby Anne Jacob-Nara, Yamo Deniz, Paul J Rowe, Elizabeth Laws, David J Lederer, Megan Hardin
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of ICS dose. Allergy (2023)
Christian Domingo Ribas, Klaus F Rabe, David J Price, Guy G O Brusselle, Michael E Wechsler, Changming Xia, Nami Pandit-Abid, Rebecca Gall, Paul J Rowe, Yamo Deniz, Juby A Jacob-Nara, Amr Radwan
Long-term efficacy of dupilumab in severe asthma by baseline oral corticosteroid dose. ERJ open research 9 (6) (2023)
Christian Domingo Ribas, Rosa M Mirapeix
From the Allergic Cascade to the Epithelium-Driven Disease: The Long Road of Bronchial Asthma. International journal of molecular sciences 24 (3) (2023)
Christian Domingo Ribas, Rosa M Mirapeix
From the Allergic Cascade to the Epithelium-Driven Disease: The Long Road of Bronchial Asthma. International journal of molecular sciences 24 (3) (2023)
Heung-Woo Park, Lieven Dupont, Surinder S Birring, Kian Fan Chung, Marta Dabrowska, Peter V Dicpinigaitis, Christian Domingo Ribas, Giovanni Fontana, Peter Gerard Gibson, Laurent Guilleminault, James Harry Hull, Marco Idzko, Peter Kardos, Hyun Jung Kim, Kefang Lai, Federico Lavorini, Eva Millqvist, Alyn Hugh Morice, Akio Niimi, Sean M Parker, Imran Satia, Jaclyn Ann Smith, Jan Willem K van den Berg, Lorcan P McGarvey
Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study. ERJ open research 9 (6) (2023)
Christian Domingo Ribas, Dave Singh
The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription. Advances in therapy (2023)
Luis Puente Maestu, Ignacio Dávila, Santiago Quirce, Astrid Crespo-Lessmann, Eva Martínez-Moragón, Javier Sola, María Luisa Nieto, Francisco-Javier Gonzalez-Barcala, Luis Cea-Calvo, Marta Sánchez-Jareño, Cristina Rivas-Pardinas, Christian Domingo Ribas
Burden of refractory and unexplained chronic cough on patients' lives: a cohort study. ERJ open research 9 (5) (2023)
Christian Domingo Ribas, Teresa Carrillo Díaz, Marina Blanco Aparicio, Eva Martínez Moragón, David Banas Conejero, M Guadalupe Sánchez Herrero, null null
REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study. Drugs 81 (15) (2021)
Christian Domingo Ribas, Jordi Rello, Ana Sogo
As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say? Drugs 79 (16) (2020)
Christian Domingo Ribas
Overlapping Effects of New Monoclonal Antibodies for Severe Asthma. Drugs 77 (16) (2018)
Christian Domingo Ribas, Xavier Pomares, Albert Navarro, María José Amengual, Concepción Montón, Ana Sogo, Rosa M Mirapeix
A step-down protocol for omalizumab treatment in oral corticosteroid-dependent allergic asthma patients. British journal of clinical pharmacology 84 (2) (2017)